Review: Mechanisms and perspective treatment of radioresistance in non-small cell lung cancer
Radiotherapy is the major treatment of non-small cell lung cancer (NSCLC). The radioresistance and toxicity are the main obstacles that leading to therapeutic failure and poor prognosis. Oncogenic mutation, cancer stem cells (CSCs), tumor hypoxia, DNA damage repair, epithelial-mesenchymal transition...
Main Authors: | Ting Zhou, Li-Ying Zhang, Jian-Zheng He, Zhi-Ming Miao, Yang-Yang Li, Yi-Ming Zhang, Zhi-Wei Liu, Shang-Zu Zhang, Yan Chen, Gu-Cheng Zhou, Yong-Qi Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-02-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1133899/full |
Similar Items
-
Recent progress of the tumor microenvironmental metabolism in cervical cancer radioresistance
by: Junying Zhou, et al.
Published: (2022-10-01) -
The therapeutic targets of N6-methyladenosine (m6A) modifications on tumor radioresistance
by: Yi Zhang, et al.
Published: (2023-07-01) -
Hedgehog signaling and the glioma-associated oncogene in cancer radioresistance
by: Li Zhang, et al.
Published: (2023-11-01) -
Prognostic risk analysis related to radioresistance genes in colorectal cancer
by: Haoren Qin, et al.
Published: (2023-01-01) -
CircRNAs in Tumor Radioresistance
by: Yining Gao, et al.
Published: (2022-10-01)